These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21053309)

  • 1. MicroRNAs in CNS injury: potential roles and therapeutic implications.
    Madathil SK; Nelson PT; Saatman KE; Wilfred BR
    Bioessays; 2011 Jan; 33(1):21-6. PubMed ID: 21053309
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell therapy for neurological disease and injury.
    Peterson DA
    Panminerva Med; 2004 Mar; 46(1):75-80. PubMed ID: 15238883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and therapies for acute CNS insults.
    Vemuganti R; Zhao H
    Metab Brain Dis; 2015 Apr; 30(2):353. PubMed ID: 24997133
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic Immune Response to Traumatic CNS Injuries-Are Extracellular Vesicles the Missing Link?
    Yates AG; Anthony DC; Ruitenberg MJ; Couch Y
    Front Immunol; 2019; 10():2723. PubMed ID: 31824504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic use of extracellular mitochondria in CNS injury and disease.
    Nakamura Y; Park JH; Hayakawa K
    Exp Neurol; 2020 Feb; 324():113114. PubMed ID: 31734316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging therapeutic role of RNA interference in disorders of the central nervous system.
    Dessy A; Gorman JM
    Clin Pharmacol Ther; 2011 Mar; 89(3):450-4. PubMed ID: 21248728
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapeutic potential of microRNAs in nervous system damage, degeneration, and repair.
    Hutchison ER; Okun E; Mattson MP
    Neuromolecular Med; 2009; 11(3):153-61. PubMed ID: 19763905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of autoantibodies in central nervous system injury.
    Zhang Y; Popovich P
    Discov Med; 2011 May; 11(60):395-402. PubMed ID: 21616038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular repair of CNS disorders: an immunological perspective.
    Chen Z; Palmer TD
    Hum Mol Genet; 2008 Apr; 17(R1):R84-92. PubMed ID: 18632702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/diseases.
    Chopp M; Zhang ZG
    Expert Opin Emerg Drugs; 2015; 20(4):523-6. PubMed ID: 26135408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The K(+)-Cl(-) Cotransporter KCC2 and Chloride Homeostasis: Potential Therapeutic Target in Acute Central Nervous System Injury.
    Wu H; Che X; Tang J; Ma F; Pan K; Zhao M; Shao A; Wu Q; Zhang J; Hong Y
    Mol Neurobiol; 2016 May; 53(4):2141-51. PubMed ID: 25941074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs change the games in central nervous system pharmacology.
    Marangon D; Raffaele S; Fumagalli M; Lecca D
    Biochem Pharmacol; 2019 Oct; 168():162-172. PubMed ID: 31251938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Synuclein in traumatic and vascular diseases of the central nervous system.
    Zeng H; Liu N; Liu XX; Yang YY; Zhou MW
    Aging (Albany NY); 2020 Nov; 12(21):22313-22334. PubMed ID: 33188159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNAs in CNS disorders.
    Kocerha J; Kauppinen S; Wahlestedt C
    Neuromolecular Med; 2009; 11(3):162-72. PubMed ID: 19536656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pivotal role of RhoA GTPase in the molecular signaling of axon growth inhibition after CNS injury and targeted therapeutic strategies.
    Gross RE; Mei Q; Gutekunst CA; Torre E
    Cell Transplant; 2007; 16(3):245-62. PubMed ID: 17503736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for CNS injury and repair using stem cells, nanomedicine, neurotrophic factors and novel neuroprotective agents.
    Sharma HS; Sharma A
    Expert Rev Neurother; 2011 Aug; 11(8):1121-4. PubMed ID: 21797653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous stem cell proliferation after central nervous system injury: alternative therapeutic options.
    Bambakidis NC; Theodore N; Nakaji P; Harvey A; Sonntag VK; Preul MC; Miller RH
    Neurosurg Focus; 2005 Sep; 19(3):E1. PubMed ID: 16190599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia as therapeutic target in central nervous system disorders.
    Fatoba O; Itokazu T; Yamashita T
    J Pharmacol Sci; 2020 Nov; 144(3):102-118. PubMed ID: 32921391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyornithine-based polyplexes to boost effective gene silencing in CNS disorders.
    Conejos-Sánchez I; Gallon E; Niño-Pariente A; Smith JA; De la Fuente AG; Di Canio L; Pluchino S; Franklin RJM; Vicent MJ
    Nanoscale; 2020 Mar; 12(11):6285-6299. PubMed ID: 31840717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of extracellular vesicle microRNAs in the central nervous system.
    Blandford SN; Galloway DA; Moore CS
    Glia; 2018 Nov; 66(11):2267-2278. PubMed ID: 29726599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.